These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24840899)

  • 1. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
    Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
    Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
    Liu X; Chang Q; Wang H; Qian H; Jiang Y
    Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis.
    Yang X; Guo Y; Du Y; Yang J; Li S; Liu S; Li K; Zhang D
    PLoS One; 2014; 9(5):e97460. PubMed ID: 24865991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis.
    Zeng Z; Wang J; Zhao L; Hu P; Zhang H; Tang X; He D; Tang S; Zeng Z
    PLoS One; 2013; 8(9):e73278. PubMed ID: 24023850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
    Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
    Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-128 as a potential diagnostic biomarker for glioma.
    Liang RF; Li M; Yang Y; Wang X; Mao Q; Liu YH
    Clin Neurol Neurosurg; 2017 Sep; 160():88-91. PubMed ID: 28704779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
    Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
    Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
    Cui Z; Lin D; Song W; Chen M; Li D
    Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
    PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.
    Zhou X; Fang S; Wang M; Xiong A; Zheng C; Wang J; Yin C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427483
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.